CAE | CAD | CON | p value | CAE vs CAD | CAE vs CON | CAD vs CON | |
---|---|---|---|---|---|---|---|
Number of patients | 30 | 30 | 30 | ||||
Age (year) | 57.37 ± 13.82 | 60.8 ± 10.84 | 56.03 ± 10.15 | 0.272 | |||
Sex (Female, %) | 20.0 | 33.3 | 16.7 | 0.271 | |||
Hypertension (%) | 60.0 | 73.3 | 43.3 | 0.061 | |||
DM (%) | 16.7 | 33.3 | 10 | 0.067 | |||
Smokers (%) | 46.7 | 46.7 | 46.7 | 1.000 | |||
Alcohol consumption (%) | 16.7 | 16.7 | 26.7 | 0.535 | |||
Family history of CAD (%) | 6.7 | 6.7 | 16.7 | 0.329 | |||
Systolic Blood Pressure (mmHg) | 132.27 ± 18.52 | 129.03 ± 19.12 | 129.57 ± 17.34 | 0.766 | |||
Diastolic Blood Pressure (mmHg) | 78.73 ± 13.48 | 74.33 ± 12.12 | 72.10 ± 11.90 | 0.119 | |||
Heart rate (bpm) | 72.90 ± 12.10 | 70.63 ± 9.17 | 69.93 ± 10.47 | 0.532 | |||
BMI (kg/m2) | 26.99 ± 3.96 | 25.36 ± 2.73 | 25.78 ± 2.73 | 0.127 | |||
ALT† (U/L) | 26(16.75–46.25) | 28.5(19.75–37) | 22.5(16.75–29.5) | 0.336 | |||
Creatinine (μmol/L) | 136.69 ± 233.97 | 79.73 ± 17.15 | 77.5 ± 12.16 | 0.166 | |||
LDL-C (mmol/L) | 2.34 ± 0.75 | 2.15 ± 0.70 | 2.48 ± 0.61 | 0.185 | |||
WBC# (109cell/L) | 6.89 ± 2.25 | 6.92 ± 1.91 | 6.59 ± 1.58 | 0.769 | |||
Neut# (109cell/L) | 5.49 ± 2.57 | 4.36 ± 1.52 | 5.77 ± 9.28 | 0.593 | |||
HGB (g/L) | 141.07 ± 21.56 | 135.5 ± 13.95 | 148.63 ± 15.93 | 0.017* | 0.557 | 0.333 | 0.004* |
PLT (109cell/L) | 211.57 ± 65.15 | 202.73 ± 63.25 | 225.57 ± 53.33 | 0.346 | |||
MPXI | 1.02 ± 3.01 | 3.22 ± 3.03 | 3.52 ± 4.25 | 0.013* | 0.016* | 0.007* | 0.745 |
Markis classification | |||||||
Type 1 | 10(33.3%) | ||||||
Type 2 | 5(16.7%) | ||||||
Type 3 | 11(36.7%) | ||||||
Type 4 | 4(13.3%) | ||||||
Ecatatic Coronary artery | |||||||
Left anterior descending | 19(63.3%) | ||||||
Left circumflex | 14(46.7%) | ||||||
Right | 16(53.3%) |